La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

BioGaia Performance dei guadagni passati

Il passato criteri di controllo 3/6

BioGaia ha registrato una crescita degli utili a un tasso medio annuo di 19.9%, mentre il settore Biotechs ha registrato utili in crescita a un tasso medio annuo di 7.7%. I ricavi sono stati in crescita a un tasso medio annuo di 14%. Il ritorno sul capitale proprio di BioGaia è 25.5% e ha margini netti di 29.3%.

Informazioni chiave

19.9%

Tasso di crescita degli utili

16.2%

Tasso di crescita dell'EPS

Biotechs Crescita del settore	0.7%
Tasso di crescita dei ricavi	14.0%
Rendimento del capitale proprio	25.5%
Margine netto	29.3%
Prossimo aggiornamento sui guadagni	12 Feb 2025

Aggiornamenti sulle prestazioni recenti

Recent updates

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Apr 25

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Apr 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Mar 26

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

Mar 09

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Feb 24

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Jul 24

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Apr 02

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Feb 21

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

Feb 09

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Feb 07

Some Shareholders May find It Hard To Increase BioGaia AB (publ)'s (STO:BIOG B) CEO Compensation This Year

Apr 29

Key Things To Consider Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Mar 25

The BioGaia (STO:BIOG B) Share Price Is Up 90% And Shareholders Are Holding On

Mar 04

CEO & President Isabelle Valerie Ducellier Just Bought 8.2% More Shares In BioGaia AB (publ) (STO:BIOG B)

Feb 11

Is BioGaia AB (publ)'s (STO:BIOG B) Latest Stock Performance A Reflection Of Its Financial Health?

Jan 26

What Type Of Shareholders Own The Most Number of BioGaia AB (publ) (STO:BIOG B) Shares?

Jan 11

How Much Are BioGaia AB (publ) (STO:BIOG B) Insiders Taking Off The Table?

Dec 27

Read This Before Buying BioGaia AB (publ) (STO:BIOG B) For Its Dividend

Dec 13

BioGaia (STO:BIOG B) Shareholders Have Enjoyed A 57% Share Price Gain

Nov 28

Ripartizione dei ricavi e delle spese

Come BioGaia guadagna e spende denaro. In base agli ultimi utili dichiarati, su base LTM.

Storia dei guadagni e delle entrate

OM:BIOG B Ricavi, spese e utili (SEK Millions )
Data	Ricavi	Guadagni	Spese G+A	Spese di R&S
30 Jun 24	1,369	402	430	101
31 Mar 24	1,300	371	415	113
31 Dec 23	1,297	365	403	107
30 Sep 23	1,273	437	399	110
30 Jun 23	1,213	415	385	111
31 Mar 23	1,186	413	375	101
31 Dec 22	1,104	374	361	107
30 Sep 22	1,036	273	341	106
30 Jun 22	952	246	302	103
31 Mar 22	867	222	262	103
31 Dec 21	785	196	231	105
30 Sep 21	767	196	206	105
30 Jun 21	725	164	198	105
31 Mar 21	766	188	197	104
31 Dec 20	747	180	198	105
30 Sep 20	767	194	203	99
30 Jun 20	802	211	210	105
31 Mar 20	780	193	213	106
31 Dec 19	768	187	209	105
30 Sep 19	770	192	200	111
30 Jun 19	778	205	195	110
31 Mar 19	756	207	192	107
31 Dec 18	742	215	181	100
30 Sep 18	702	206	173	94
30 Jun 18	675	197	166	86
31 Mar 18	631	181	153	78
31 Dec 17	615	181	149	76
30 Sep 17	584	179	143	70
30 Jun 17	562	172	139	69
31 Mar 17	542	163	132	67
31 Dec 16	535	160	129	64
30 Sep 16	500	138	118	57
30 Jun 16	480	129	114	53
31 Mar 16	478	130	111	52
31 Dec 15	483	138	112	53
30 Sep 15	500	130	115	60
30 Jun 15	474	119	114	59
31 Mar 15	432	97	115	58
31 Dec 14	482	147	107	54
30 Sep 14	451	146	102	46
30 Jun 14	433	145	98	43
31 Mar 14	426	142	93	42
31 Dec 13	316	62	94	41

Guadagni di qualità: BIOG B ha guadagni di alta qualità.

Margine di profitto in crescita: Gli attuali margini di profitto netti di BIOG B (29.3%) sono inferiori rispetto allo scorso anno (34.2%).

Flusso di cassa libero e analisi degli utili

Analisi della crescita degli utili nel passato

Andamento degli utili: Gli utili di BIOG B sono cresciuti del 19.9% all'anno negli ultimi 5 anni.

Accelerare la crescita: BIOG B ha avuto una crescita negativa degli utili nell'ultimo anno, quindi non può essere confrontata con la sua media quinquennale.

Guadagni vs Settore: BIOG B ha avuto una crescita negativa degli utili ( -3.3% ) nell'ultimo anno, rendendo difficile il confronto con la media del settore Biotechs ( -0.08% ).

BioGaia Performance dei guadagni passati

Il passato criteri di controllo 3/6

Informazioni chiave

Aggiornamenti sulle prestazioni recenti

Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.80 in 2Q 2023)

BioGaia AB (publ) to Report Fiscal Year 2024 Results on Feb 12, 2025

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Recent updates

Vice President of Marketing recently sold kr407k worth of stock

Executive VP & CFO recently sold kr11m worth of stock

Vice President of Marketing exercised options to buy kr579k worth of stock.

Second quarter 2024 earnings released: EPS: kr1.10 (vs kr0.80 in 2Q 2023)

BioGaia AB (publ) to Report Fiscal Year 2024 Results on Feb 12, 2025

First quarter 2024 earnings released: EPS: kr1.21 (vs kr1.15 in 1Q 2023)

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Full year 2023 earnings: EPS and revenues exceed analyst expectations

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

BioGaia (STO:BIOG B) Will Pay A Larger Dividend Than Last Year At SEK6.90

BioGaia (STO:BIOG B) Has Announced That It Will Be Increasing Its Dividend To SEK6.90

Price target increased by 22% to kr140

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes an Extra Dividend

Here's Why We Think BioGaia (STO:BIOG B) Might Deserve Your Attention Today

BioGaia AB (publ) to Report First Half, 2024 Results on Jul 07, 2024

Third quarter 2023 earnings released

BioGaia AB (publ), Annual General Meeting, Apr 26, 2024

Biogaia AB (Publ) Provides Preliminarily Earnings Guidance for Third Quarter 2023

Biogaia AB (Publ) Appoints Theresa Agnew as CEO

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

BioGaia AB (publ) Introduces BioGaia Prodentis KIDS in Sweden

BioGaia Appoints Theresa Agnew as New CEO, Effective September 25, 2023

Second quarter 2023 earnings released

BioGaia's probiotic Protectis increases SARS-CoV-2 antibody response in adults

Does BioGaia (STO:BIOG B) Deserve A Spot On Your Watchlist?

Less than half of directors are independent

First quarter 2023 earnings released

BioGaia AB (Publ) Approves Dividend for 2022

Upcoming dividend of kr2.90 per share at 2.8% yield

A Look At The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2022 earnings: EPS exceeds analyst expectations

Independent Director recently bought kr51k worth of stock

Price target increased by 9.1% to kr120

Full year 2022 earnings released: EPS: kr3.70 (vs kr1.94 in FY 2021)

BioGaia AB (publ) Proposes Ordinary Dividend

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Price target decreased to kr102

Third quarter 2022 earnings: Revenues exceed analyst expectations

Investor sentiment improved over the past week

BioGaia AB (publ) Provides Earnings Guidance for the Third Quarter of 2022

Do BioGaia's (STO:BIOG B) Earnings Warrant Your Attention?

Second quarter 2022 earnings: EPS and revenues exceed analyst expectations

Does This Valuation Of BioGaia AB (publ) (STO:BIOG B) Imply Investors Are Overpaying?

Biogaia AB (publ) Provides Earnings Guidance for the Second Quarter of 2022

Price target increased to kr620

BioGaia AB (publ) Approves Extra Dividend

First quarter 2022 earnings: Revenues exceed analyst expectations

Upcoming dividend of kr14.92 per share

Price target increased to kr570

BioGaia AB (publ) Provides Earnings Guidance for the First Quarter of 2022

BioGaia AB (publ) Proposes Dividend, Payable on 13 May 2022

Calculating The Intrinsic Value Of BioGaia AB (publ) (STO:BIOG B)

Full year 2021 earnings: EPS and revenues exceed analyst expectations

BioGaia's (STO:BIOG B) Shareholders Will Receive A Bigger Dividend Than Last Year

Consensus revenue estimates increase by 10%

Need To Know: Analysts Are Much More Bullish On BioGaia AB (publ) (STO:BIOG B) Revenues

BioGaia's (STO:BIOG B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2021 earnings: EPS and revenues exceed analyst expectations

Biogaia AB (Publ) Proposes Ordinary Dividend

BioGaia's Probiotic Reduces Inflammation in Patients with Diverticulitis

BioGaia AB (publ) Announces First Patient Enrolled in Phase II Clinical Study Evaluating BGP345A for the Treatment of Opioid Induced Constipation (OIC-1)

Third quarter 2021 earnings released

Price target increased to kr533

Second quarter 2021 earnings released: EPS kr2.71 (vs kr4.56 in 2Q 2020)

Consensus forecasts updated

BioGaia AB (publ) (OM:BIOG B) acquired remaining 8% stake in MetaboGen AB for SEK 11.4 million.